关键词:
Sanhua decoction
ischemic stroke
network pharmacology
molecular docking technology
摘要:
Objective The aim of this study was to explore the action mechanism of Sanhua decoction in treating ischemic stroke through network pharmacology and molecular docking *** Active components and related targets of Sanhua decoction were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform.A“drug-active component-target”network was constructed,and core components were selected throughtopological *** targets related to ischemic stroke were screened based on the Online Mendelian Inheritance in Man(OMIM),Therapeutic Target Database(TTD),GeneCards,DrugBank,and PharmGKB *** intersection of active component–related targets and ischemic stroke disease targets was identified to obtain potential targets of Sanhua decoction for treating ischemic stroke,represented using a Venn *** STRING database was used to construct a protein–protein interaction(PPI)network of potential targets and filter for core *** Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis of core targets were performed using the DAVID database and Metascape *** docking verification of core targets and core components was conducted using *** A total of 52 active components and 142 related targets were screened from Sanhua decoction,with core active components including luteolin,nobiletin,β-sitosterol,eucalyptol,and *** were 2,991 ischemic stroke–related targets,with 98 potential targets identified in the intersection with active component–related *** analysis of the PPI network analysis revealed 23 core targets,including serine/threonine-protein kinase 1(AKT1),tumor protein p53(TP53),and mitogen-activated protein kinase 3(MAPK3).Enrichment analysis obtained 35 GO results and 41 signaling *** docking results indicated good binding between core components and core *** Multi